A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Clinical trial NCT00744367 · COMPLETED
Trial details
- NCT number
- NCT00744367
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2010-11-01
- Enrollment
- 326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.